• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Revance Biotech

Anonymous board for Revance Biotech
Replies
64
Views
7K
anonymous
Replies
1
Views
423
anonymous
Replies
13
Views
1K
anonymous
Replies
133
Views
15K
anonymous
Replies
9
Views
2K
anonymous
Replies
30
Views
6K
Revance is my B+tc*
Replies
33
Views
4K
anonymous
Replies
6
Views
2K
anonymous
Replies
14
Views
4K
anonymous
Replies
31
Views
6K
anonymous
Replies
4
Views
1K
anonymous
Replies
14
Views
4K
anonymous
NSM
Replies
5
Views
2K
anonymous
Replies
0
Views
797
anonymous